← Back to Search

Anesthesia Handoff Tool for Reducing Postoperative Complications

Phase 2
Waitlist Available
Led By Aubrey Samost-Williams, MD, MS
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing non-cardiac surgery in the main operating rooms (e.g. not the endoscopy suite or labor and delivery ward)
Be older than 18 years old
Must not have
American Society of Anesthesiologists (ASA) Physical Status 6 (organ donors)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days after surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using a specific tool during the handoff of anesthesia providers in surgery can improve patient outcomes. It also wants to test a scale that measures how well healthcare providers share information and

Who is the study for?
This trial is for surgical patients who could experience postoperative complications. Specific eligibility criteria are not provided, so it's unclear who exactly can participate or what conditions might prevent someone from joining.
What is being tested?
The study is testing a new semi-structured intraoperative anesthesia handoff tool against the standard of care to see if it improves patient outcomes after surgery. It also evaluates a scale called the 5-PSMMS in healthcare settings.
What are the potential side effects?
Since this trial involves procedural changes rather than medications, traditional side effects are not applicable. However, there may be risks associated with miscommunication or errors during the handoff process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a non-heart-related surgery in the main operating room.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am an organ donor declared brain dead.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants that show post-operative complications that have been associated with intraoperative handoffs
Secondary study objectives
Number of participants that show peri-operative complications that have been associated with intraoperative handoffs

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Epic Health Record semi-structured handoff cognitive aidExperimental Treatment1 Intervention
Group II: Usual careActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
947 Previous Clinical Trials
337,489 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
366 Previous Clinical Trials
405,140 Total Patients Enrolled
Aubrey Samost-Williams, MD, MSPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~5000 spots leftby Apr 2026